EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

5Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Presentation with massive systemic embolization as the initial manifestation of occult malignancy is infrequent. The standard management of cancer-related arterial thromboembolism has not yet been established. Case presentation: We described a case of Trousseau’s syndrome resulting in acute ischemic stroke concomitant with multiple embolizations in the spleen and kidney during oral administration of dabigatran for pulmonary embolism preceding the diagnosis of a malignant tumor. A cancer-related hypercoagulable state was suspected because the patient was admitted to the neurology department due to acute ischemic stroke with three territory infarcts on diffusion-weighted imaging (DWI) in the absence of identifiable conventional risk factors and brain vessel narrowing. The patient was subsequently diagnosed with epidermal growth factor receptor (EGFR) mutation–positive non-small-cell lung cancer (NSCLC) (stage IV) with pleural metastasis. Administration of low-molecular-weight heparin followed by long-term dabigatran under effective cancer therapy comprising gefitinib and subsequent chemotherapy did not cause stroke relapse during the 1-year follow-up. Conclusions: This case suggests that cancer-related hypercoagulability should be considered an important etiology for stroke patients who develop unexplained disseminated acute cerebral infarction without conventional stroke risk factors, especially concomitant with multiple organ embolization. Novel oral anticoagulants may be an alternative therapy for the long-term management of cancer-related arterial thromboembolism under effective cancer therapy.

References Powered by Scopus

Cerebrovascular complications in patients with cancer

535Citations
N/AReaders
Get full text

Risk of Arterial Thromboembolism in Patients With Cancer

495Citations
N/AReaders
Get full text

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

249Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients

11Citations
N/AReaders
Get full text

Clinical analysis of twenty-one cases of acute ischemic stroke related to Trousseau syndrome

3Citations
N/AReaders
Get full text

The influence of baseline platelet on mortality risk in stroke and cancer patients: a cross-sectional analysis of the NHANES database

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, Z., Miao, J., Wang, L., Liu, Y., Ji, H., Zhang, X., & Cui, L. (2021). EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report. BMC Neurology, 21(1). https://doi.org/10.1186/s12883-021-02236-2

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

50%

Lecturer / Post doc 1

25%

Researcher 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Environmental Science 1

20%

Save time finding and organizing research with Mendeley

Sign up for free